Skip to main content

Celularity, Inc. (CELU)

NASDAQ: CELU · IEX Real-Time Price · USD
6.07 -0.22 (-3.50%)
Dec 3, 2021 4:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019
Revenue
14.2821.15
Revenue Growth
-32.48%-
Cost of Revenue
4.936.32
Gross Profit
9.3514.82
Selling, General & Admin
31.3441.79
Research & Development
52.7146.05
Other Operating Expenses
132.79122.24
Operating Expenses
216.84210.09
Operating Income
-207.49-195.26
Interest Expense / Income
2.350
Other Expense / Income
3.0972.73
Pretax Income
-212.93-267.99
Income Tax
-4.7-56.11
Net Income
-208.23-211.88
Net Income Common
-208.23-211.88
Shares Outstanding (Basic)
2424
Shares Outstanding (Diluted)
2424
Shares Change
0.38%-
EPS (Basic)
-8.69-8.88
EPS (Diluted)
-8.69-8.88
Free Cash Flow Per Share
-3.80-4.12
Gross Margin
65.46%70.10%
Operating Margin
-1453.22%-923.36%
Profit Margin
-1458.42%-1001.94%
Free Cash Flow Margin
-637.53%-464.69%
Effective Tax Rate
2.21%20.94%
EBITDA
-202.41-261.81
EBITDA Margin
-1417.60%-1238.04%
EBIT
-210.58-267.99
EBIT Margin
-1474.85%-1267.29%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).